Heinz Lubenau

Heinz Lubenau

Company: Vaximm GmbH

Job title: Chief Executive Officer & Co-Founder

Email: heinz.lubenau@vaximm.com


Oral Administration of DNA-Based Vaccines to Stimulate a Strong Immune Response Towards Mutated Cancer Antigen(s) 12:30 pm

Analysing the benefits of oral administration of DNA as opposed to injection Identifying the success of stimulating an immune response Presenting unequivocal clinical data proving the success of the method    Read more

day: Track B - Day 1 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.